Inhibition of Melanoma Growth by Ex Vivo Expanded Tumor‐Spec…
Emerging
1
Citations41
Refs2025
Year
Search Works
Work Details
- DOI 10.1002/eji.202451676
- PMID https://pubmed.ncbi.nlm.nih.gov/40440562
- OpenAlex ID W4410849449
- Type Article
- Language EN
- Published 01 May 2025
- Volume 55 (5)
- Pages e202451676
- Source European Journal of Immunology
- Publisher Wiley
- FWCI 0.37
- Countries 1
- Institutions 1
- Added 10 Oct 2025
- Updated 31 Oct 2026
External Links
MENU
0
Inhibition of Melanoma Growth by Ex Vivo Expanded Tumor‐Specific CD8+ T Cells Is Dependent on the Configuration of Nanoscale Artificial APCs
Article 2025 EN
Adoptive T-cell therapy is an emerging immunotherapeutic strategy for treating cancer, but the compromised quality of CD8+ T-cells limits the therapeutic efficacy. Traditional methods involving polyclonal expansion of CD8+ T-cells mainly prioritize yielding a high quantity of CD8+ T-cells. However, the antigen-specificity of ex vivo expanded CD8+ T-cells and the ability to produce cytolytic molecu…
1
Citations
41
References
8
Authors
0.37
FWCI
Citations by Year
Last 1 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
8 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Antara Mondal | National Institute of Immunolo… (IN) | — |
| 2 | Faisal Jamal | National Institute of Immunolo… (IN) | — |
| 3 | Arpita Das | National Institute of Immunolo… (IN) | — |
| 4 | Arnab Kumar Sahoo | National Institute of Immunolo… (IN) | — |
| 5 | Khushboo Chaudhary | National Institute of Immunolo… (IN) | — |
| 6 | Sarmili Chowdhury | National Institute of Immunolo… (IN) | — |
| 7 | Aakriti Jha | National Institute of Immunolo… (IN) | |
| 8 | Santiswarup Singha Corresponding | National Institute of Immunolo… (IN) |
Related Works
10Data: OpenAlex